Critically, it is unknown whether HMCN1 represents a conserved oncogenic driver across cancers or a context-dependent factor, and its potential role as a master regulator of central processes like epithelial-mesenchymal transition (EMT) is poorly defined. The gene discussed is HMCN1; the disease is cancer.